ENT Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

ENT Devices Market By Device Type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, And Others) Procedure Type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, And Others) By Usability (Disposable And Reusable) By Age Group (Pediatric And Adults) By End-User (Hospitals, ENT Clinics, And Others) by geography is estimated to register a significant growth during the forecast period from 2024-2030 owing to surge in prevalence of ENT problems and technological advances in ENT devices.

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030. The positive growth in the ENT devices market is due to the rising prevalence of various Ear, Nose, and Throat problems as a result of injuries, viral and bacterial infections, chronic diseases like cancer, allergic rhinitis, and an increasing geriatric population. The growing cases of hearing loss or deafness are another major driver driving the market growth of ENT devices. The various technological developments for minimally invasive surgical ENT devices are another matter of fact for the growth of this market. The boom in plastic surgeries over many years also explains the growing need for effective ENT devices.

ENT Devices Market Dynamics:

The growth of ENT devices is owing to various factors including chronic diseases, injuries, infections, increasing age, and others.

The rising prevalence of head and neck cancer which requires thorough diagnosis and surgery for removal of the tumour is an important factor for market growth. According to National Cancer Institute 2022, out of total cancer cases in the US, the cases of head and neck cancer accounts for 4%. The increase in bacterial and viral infections worldwide affecting ear, nose, and throat health is also causing a rise in the demand for ENT diagnostic and surgical devices. For instance, according to the World Health Organization (WHO) data published in 2022, the probability of an individual facing long-term effects such as loss of hearing, speech, and communication after getting recovered from bacterial meningitis is 1 out of 5. Along with this the decrease or overall loss of hearing ability with increasing age requires immediate action in form of hearing aids and implants, for which surgeries are done eventually leading to the growth of the ENT devices market.

The other important factor for the ENT devices market growth is the new technological developments happening for effective but minimally invasive procedures at affordable costs. For instance, Georgia Tech researchers have developed affordable ultra-low-cost hearing aid to help millions of people suffering from age-related hearing loss.

The sedentary lifestyle is another driving factor for the ENT devices market growth as it leads to lifestyle-based diseases including obstructive sleep apnoea and other breathing problems. According to American Academy of Sleep Medicine, around 30 million American adults suffer from obstructive sleep apnoea (OSA). The acute and chronic cases of seasonal allergies including allergic rhinitis, and sinusitis owing to certain allergens also impact the ENT device market positively. As per the latest data available from World Allergy Organization 2020, currently around 400 million people are suffering from allergic rhinitis worldwide and most of them are neither diagnosed nor treated.

The ENT device market is also seeing positive growth due to the rise in cosmetic surgeries happening worldwide. People getting more inclined toward enhancing their physical appearances and the availability of minimally invasive and safe procedures at affordable rates are further driving the cosmetic surgery industry and thus leading to remarkable growth in the ENT devices market growth also.

However, the lack of skilled ENT specialists and limited access to affordable ENT products in developing nations are certain key factors hampering the ENT devices market growth.

During the period of the COVID-19 pandemic, the ENT device market growth has shown some decline due to shifted primary focus on first treating patients suffering from Coronavirus. The hospitals closed down the ENT department during the pandemic owing to lockdown and also to avoid any chance of spread of infection. However, as everything has been normalized post-COVID-19, and with the increase in public awareness of ENT health and regular check-ups, there is a growth in ENT surgeries. Thus, the market seems to grow effectively during the forecast period from 2024 to 2030.

ENT Devices Market Segment Analysis:

ENT Devices Market by Device type (Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints, and Others) Procedure type (Laryngoscopy, Functional Endoscopic Sinus Surgery, Tonsillectomy, Adenoidectomy, and Others) Usability (Disposable and Reusable), Age Group (Paediatric and Adults), End-User (Hospitals, ENT Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the device type segment, hearing implants are going to register significant growth in revenue in the ENT devices market during the forecast period (2024-2030). This can be ascribed to the rising prevalence of hearing loss owing to factors such as aging, inappropriate use of drugs and medications, infections like rubella, syphilis, and jaundice, among others. For instance, according to World Health Organization (WHO) 2022, the probability of suffering even a slight degree of hearing loss by 2050 will be 1 out of 4.

Also, the technological advancement in form of artificial intelligence, small device size, and minimum invasiveness in solving hearing impairment can prove to be an important factor for hearing implant market growth. For example, according to National Institute on Deafness and Other Communication Disorders (2023), approximately 736,900 registered device implantation have been performed in December 2019 worldwide. This gives an insight into the hearing implant market growth.

Therefore, considering the growing demand for this product type, numerous new products are also being launched in the market. For instance, in August 2022 Cochlear Limited, pioneers in implantable hearing solutions announced the launch of the world's smallest off-the-ear cochlear implant sound processor Nucleus® Kanso® 2 in Singapore which helps in improving hearing in people with hearing loss. Therefore, considering the prevalence of hearing loss and the growing need for hearing implants among end-users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global ENT devices market during the forecast period.

North America is expected to dominate the overall ENT Devices Market:

The ENT device market is going to see prosperity in the North America region specifically owing to key factors including underlying diseases like cancer, allergic rhinitis, sinusitis, new technological advancements, high-tech medical facilities, government support, and awareness regarding ENT health among others.

The cases of allergic sinusitis are highly prevalent in the United States. Sinusitis is an illness of the nose and sinuses which is marked by symptoms like nasal blockage, inflammation, pain in the noses and sinuses, fever, nasal discharge, and others. According to the Centers for Disease Control and Prevention (CDC) 2022, around 28.9 million adults were diagnosed with sinusitis in the U.S in the year 2018. The large population affected by chronic sinusitis requires proper diagnosis and treatment in terms of surgery thereby driving the growth of the ENT devices market in the North America region.

Further, cases of hearing impairment are also on the rise owing to bacterial and viral infections, injuries, noise pollution, and a growing geriatric population. Hearing aids and cochlear implants are widely used for such problems in the country. According to the U.S. Food and Drug Administration (FDA) 2022, roughly around 118,100 and 65,000 cochlear implants have been implanted in adults and children respectively in the U.S. in the year 2019. This shows an enormous market growth opportunity for ENT devices in the U.S. region.

Thyroid cancer incidences are another key driver for growth in the ENT devices market in the region. For instance, according to the American Cancer Society 2022, the estimated number of new cases of thyroid cancer in the US for the year 2022 is 43,800 out of which 31,940 new cases in women and 11,860 in men. An adequate diagnosis and surgical treatments like minimally invasive, video-assisted thyroidectomy, endoscopic or robotic thyroidectomy are suggested by ENT specialists for thyroid surgery.

Head and neck cancer also drives the growth of the ENT devices market in the US. As per the National Cancer Institute 2022, estimated head and neck cancer cases diagnosed were more than 68,000 in the year 2023 in the United States.

Apart from general treatment options including surgery of the head and neck, and laryngectomy, sometimes plastic and reconstructive surgery may also require depending upon the severity and thus leading to an overall increase in the ENT devices market growth in the region.

ENT Devices Market Key Players:

Some of the key market players operating in the ENT Devices market include Medtronic, Starkey, Smith and Nephew Plc., Fude Technology Group Limited, Cochlear Limited, Olympus America, Stryker Corporation, Johnson & Johnson Services, Inc., Sonova Holding AG, Atos medical Ab, MED-EL Medical Electronics, Firefly Global, RION Co., Ltd., GN Store Nord A/S, Welch Allyn®, Karl Storz Gmbh & co., Demant A/S, B. Braun Melsungen AG, WS Audiology A/S, PENTAX Medical, among others.

Recent Developmental Activities in ENT Devices Market:

In January 2022, Cochlear Limited (ASX: COH) received U.S. Food and Drug Administration (FDA) approval for its Cochlear(TM) Nucleus® which offers an implant for unilateral hearing loss (UHL)/single-sided deafness (SSD).

In August 2022, 3NT Medical received U.S. Food and Drug Administration (FDA) approval for Peregrine Drivable ENT Scope which allows ENT specialists to visualize in-depth intra-sinus anatomy with minimal resection.

In November 2020, SafKan Health received FDA clearance for its OtoSet which is the first automated ear cleaning system.

Key Takeaways from the ENT Devices Market Report Study

• Market size analysis for current ENT devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ENT devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global ENT devices market.
• Various opportunities are available for the other competitor in the ENT devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current ENT devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for ENT devices market growth in the coming future?

Target Audience who can be benefited from this ENT Devices Market Report Study

• ENT devices products providers
• Research organizations and consulting companies
• ENT devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in ENT devices
• Various end-users who want to know more about the ENT devices market and the latest technological developments in the ENT devices market.

Frequently Asked Questions for ENT Devices Market:

1. What are ENT devices?

ENT Devices are medical devices that are employed in the diagnosis, treatment, and management of ear, nose, and throat health.

2. What is the market for Global ENT devices?

The global ENT devices market was valued at USD 16.80 billion in 2023, growing at a CAGR of 6.89% during the forecast period from 2024 to 2030 to reach USD 25.02 billion by 2030.

3. What are the drivers for the global ENT devices Market?

The ENT device market is slated to witness prosperity owing to factors such as the growing prevalence of bacterial and viral infections, chronic diseases such as cancer, an increasingly sedentary lifestyle, a growing aging population base susceptible to the development of hearing loss, and the growing focus on improving the safety and usability of ENT devices for end-users are further expected to result in the appreciable revenue growth in the ENT devices market during the forecast period (2024-2030).

4. Who are the key players operating in the global ENT devices Market?

Some of the key market players operating in the ENT Devices market include Medtronic, Starkey, Smith and Nephew Plc., Fude Technology Group Limited, Cochlear Limited, Olympus America, Stryker Corporation, Johnson & Johnson Services, Inc., Sonova Holding AG, Atos medical Ab, MED-EL Medical Electronics, Firefly Global, RION Co., Ltd., GN Store Nord A/S, Welch Allyn®, Karl Storz Gmbh & co., Demant A/S, B. Braun Melsungen AG, WS Audiology A/S, PENTAX Medical, among others.

5. Which region has the highest share in the ENT devices market?

North America is expected to dominate the overall ENT devices market during the forecast period from 2024 to 2030. This can be ascribed to the presence of a large patient pool associated with hearing impairment, and chronic diseases like cancer, rhinitis, and sinusitis. The increase in obstructive sleep apnoea cases also increases the market for ENT devices in the region.